| Literature DB >> 1433181 |
P C Unangst1, G P Shrum, D T Connor, R D Dyer, D J Schrier.
Abstract
A series of 1,2,4-oxadiazoles and 1,2,4-thiadiazoles containing a 2,6-di-tert-butylphenol substituent were prepared and evaluated as dual inhibitors of 5-lipoxygenase and cyclooxygenase in rat basophilic leukemia (RBL-1) cells. Several of these compounds show oral efficacy in the rat carrageenan footpad edema (CFE) and mycobacterium footpad edema (MFE) antiinflammatory models, without concomitant gastric ulceration. Structure-activity relationships are discussed. The best compounds (ID40 values in MFE of 3-8 mg/kg po) contain guanidine-derived substituents on the heterocyclic ring.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1433181 DOI: 10.1021/jm00098a015
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446